Clinical trial · Interventional
Evaluation of Safety and Efficacy of Supportan® Drink
NCT06902402CI-TRIAL-00125714recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260929-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to demonstrate safety and efficacy of Supportan® Drink
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Malnutrition (Calorie) | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Supportan® Drink | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Supportan® Drink
- interventionNames
- Dietary Supplement: Supportan® Drink
Primary outcomes (1)
- measure
- Change in body weight from Baseline to end of treatment at Week 4 (Week 4 -Baseline)
- timeFrame
- 4 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1\. Patients receiving chemotherapy and/or radiotherapy, or immunotherapy, or targeted therapy; Exclusion Criteria: 1\. Patient with documented diagnosis of liver, kidney or heart disease in the hospital's electronic medical record (EMR); severity of disease evaluated by Investigator as not being suitable to participate in this study;
References
Publications (0)
Data not yet available
No reference posted for this study.